Related Experiment Video
Updated: Jul 19, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Heart repair and stem cells
Linda W van Laake1, Rutger Hassink, Pieter A Doevendans
1Hubrecht Laboratory, Interuniversity Cardiology Institute of the Netherlands, Utrecht, the Netherlands.
Insights
Bone marrow cells may offer therapeutic benefits for heart conditions, but not through direct replacement of cardiac muscle. Research explores alternative stem cell sources for repairing heart muscle post-myocardial infarction.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Cell transplantation therapy is being investigated for various medical conditions, with a significant focus on cardiac applications.
- Bone marrow-derived cell preparations have entered clinical trials for heart conditions.
- Current understanding suggests bone marrow's benefit is not due to transdifferentiation into cardiac myocytes.
Purpose of the Study:
- To review the literature on potential stem cell sources for cardiac myocyte replacement after myocardial infarction.
- To address the question of whether stem cells can regenerate functional heart muscle.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies investigating stem cell potential in cardiac repair.
Main Results:
- The review examines the existing research on stem cell sources for cardiac regeneration.
- Evidence regarding the efficacy and mechanisms of different stem cell types is evaluated.
Conclusions:
- While bone marrow cells show some therapeutic promise, they are unlikely to replace damaged cardiac myocytes directly.
- Further research is needed to identify and validate alternative stem cell sources capable of regenerating heart muscle post-myocardial infarction.
Abstract:
Of the medical conditions currently being discussed in the context of possible treatments based on cell transplantation therapy, few have received more attention than the heart. Much focus has been on the potential application of bone marrow-derived cell preparations, which have already been introduced into double-blind, placebo-controlled clinical trials. The consensus is that bone marrow may have therapeutic benefit but that this is not based on the ability of bone marrow cells to transdifferentiate into cardiac myocytes. Are there potential stem cell sources of cardiac myocytes that may be useful in replacing those lost or dysfunctional after myocardial infarction? Here, this question is addressed with a review of the recent literature.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Culture
iPS Cell Differentiation
Healing I: Introduction
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...

